Neuraxial Labor Analgesia and the Incidence of Postpartum Depression

Sponsor
Peking University First Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02823418
Collaborator
Beijing Obstetrics and Gynecology Hospital (Other), Beijing Haidian Maternal and Child Health Hospital (Other)
599
32.8

Study Details

Study Description

Brief Summary

Postpartum depression (PPD) affects approximately 15% of women during the first year after giving birth, and is common across cultures. The etiology of postpartum depression is not totally clear. The severe pain experienced during childbirth was reported to be associated with the development of postpartum depression. The purpose of the present study is to evaluate whether use of neuraxial labor analgesia can reduce the incidence of postpartum depression.

Condition or Disease Intervention/Treatment Phase
  • Procedure: No neuraxial labor analgesia
  • Procedure: Neuraxial labor analgesia

Detailed Description

Postpartum depression (PPD) affects approximately 15% of women during the first year after giving birth, and is common across cultures. In postpartum Chinese women, the reported incidence ranged from 6.5% to 29.5%.

The etiology of postpartum depression is not totally clear. Identified risk factors include previous maternal blues, unplanned pregnancy, lack of marital or social support, and previous psychiatric illnesses. Furthermore, the severe pain experienced during childbirth was reported to be associated with the occurrence of postpartum depression.

A recent study of the investigators found that use of epidural analgesia during labor was associated with decreased risk of postpartum depression. However, several limitations existed in that study and further evidence is needed to reconfirm the finding. The purpose of the present study is to reevaluate whether use of neuraxial labor analgesia can reduce the incidence of postpartum depression.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
599 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Impact of Neuraxial Labor Analgesia on the Incidence of Postpartum Depression: a Prospective, Observational, Multicenter Cohort Study
Actual Study Start Date :
Aug 1, 2014
Actual Primary Completion Date :
May 29, 2015
Actual Study Completion Date :
Apr 25, 2017

Arms and Interventions

Arm Intervention/Treatment
No neuraxial labor analgesia

For patients who do not accept neuraxial labor analgesia, analgesics will be prescribed by obstetricians according to routine practice.

Procedure: No neuraxial labor analgesia
Neuraxial analgesia will not be performed. Analgesics will be prescribed by the obstetricians according to routine practice.

Neuraxial labor analgesia

For patients who accept neuraxial labor analgesia, epidural analgesia or combined spinal-epidural analgesia will be provided when the cervix is dilated to 1 cm or more and continued until the cervix is fully dilated to 10 cm.

Procedure: Neuraxial labor analgesia
Epidural or combined spinal-epidural labor analgesia will be performed when the cervix is dilated to 1 cm or more and continued until the cervix is fully dilated to 10 cm.

Outcome Measures

Primary Outcome Measures

  1. The incidence of postpartum depression [At 42 days after delivery]

    Postpartum depression will be defined by a score of 10 or more on the Edinburgh Postnatal Depression Scale.

Secondary Outcome Measures

  1. The mode of delivery [At the time of delivery]

    The mode of delivery includes spontaneous delivery, instrumental delivery, and Caesarean delivery.

  2. Neonatal Apgar score [At 1 and 5 minutes after delivery]

    The Apgar score ranges from 0 to 10, with higher score indicating a better outcome. Scores 7 and above are generally normal; 4 to 6, fairly low; and 3 and below are generally regarded as critically low and cause for immediate resuscitative efforts.

  3. Status of baby feeding [At 24 hours and 42 days after delivery]

    The mode of baby feeding include breast feeding, mixed feeding, and formula feeding.

  4. Severity of pain [At 24 hours and 42 days after delivery]

    Severity of pain is evaluated with Numeric Rating Scale (NRS), where 0 indicates no pain and 10 the most severe pain.

  5. Persistent pain [At 42 days after delivery]

    Persistence pain is defined as a NRS pain score ≥1 that persisted since childbirth.

  6. Persistent pain affecting daily life [At 42 days after delivery]

    One of the following activities (including walking, mood, sleep or concentration) is affected by persistent pain, as judged by parturients themselves.

Other Outcome Measures

  1. 2-year depression [Assessed between 23 to 24 months after childbirth.]

    2-year depression is assessed with the Edinburgh Postnatal Depression Scale, a score of 10 or higher is defined as the presence of depression.

  2. Degree of social support [Assessed between 23 to 24 months after childbirth.]

    Degree of social support is assessed with the Social Support Rating Scale, score range 11 to 62, with higher score indicating better social support.

  3. Maternal body weight [Assessed between 23 to 24 months after childbirth.]

    Maternal body weight

  4. Maternal height [Assessed between 23 to 24 months after childbirth.]

    Maternal height

  5. Duration of breast-feeding [Up to 24 months after childbirth.]

    Duration of breast-feeding

  6. Start of complementary feeding [Up to 24 months after childbirth.]

    Start of complementary feeding

  7. Chronic pain after childbirth [Up to 24 months after childbirth.]

    Defined as persistent or recurrent pain that lasted for more than 3 months after childbirth.

  8. Chronic pain affecting daily life [Up to 24 months after childbirth.]

    Defined as chronic pain that interfered daily life activities including walking, mood, sleep or concentration, as judged by parturients themselves.

  9. Maternal disease after childbirth [Up to 24 months after childbirth]

    Refer to any new-onset disease that occurs after childbirth and requires medical therapy or surgical procedures.

  10. Another childbirth [Up to 24 months after the first childbirth.]

    Another childbirth

  11. Mental Development Index [Assessed between 23 to 24 months of age.]

    Assessed with the Mental Scale subtest of the Bayley Scales of Infant Development-Chinese Revision. The subtest includes 163 items and assesses adaptive behavior, language and cognitive ability. The raw score of successfully completed items is converted to the standardized Mental Development Index. The average score of Mental Development Index in normal urban children is 100 with a SD of 15, with higher score indicating better development.

  12. Psychomotor Development Index [Assessed between 23 to 24 months of age.]

    Assessed with the Motor Scale subtest of the Bayley Scales of Infant Development-Chinese Revision. The subtest includes 81 items and assesses gross and fine motor skills. The raw score of successfully completed items is converted to the standardized Psychomotor Development Index. The average score of Psychomotor Development Index in normal urban children is 100 with a SD of 15, with higher score indicating better development.

  13. Child body weight [Assessed between 23 to 24 months of age.]

    Child body weight

  14. Child height [Assessed between 23 to 24 months of age.]

    Child height

  15. Pediatric disease [Up to 24 months of age.]

    Indicates any congenital or acquired disease that requires medical therapy or surgical procedures.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 34 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Primiparae between 18 and 34 years of age with term single cephalic pregnancy;

  2. Admitted to the delivery room during daytime working hours (from 8 am to 5 pm).

  3. Preparing to deliver vaginally.

Exclusion Criteria:
  1. History of psychiatric disease (indicate those that are diagnosed before or during pregnancy by psychiatrists);

  2. Presence of contraindications to epidural analgesia, which includes: (1) History of infectious disease of the central nervous system (poliomyelitis, cerebrospinal meningitis, encephalitis, etc.); (2) History of spinal or intra-spinal disease (trauma or surgery of spinal column, intra-spinal canal mass, etc.); (3) Systemic infection (sepsis); (4) Skin or soft tissue infection at the site of epidural puncture; (5) Coagulopathy.

  3. Other reasons that are considered unsuitable for study participation.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Peking University First Hospital
  • Beijing Obstetrics and Gynecology Hospital
  • Beijing Haidian Maternal and Child Health Hospital

Investigators

  • Principal Investigator: Dong-Xin Wang, MD,PHD, Peking University First Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dong-Xin Wang, Professor and Chairman, Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital
ClinicalTrials.gov Identifier:
NCT02823418
Other Study ID Numbers:
  • 2014[712]
  • ChiCTR-OCH-14004888
First Posted:
Jul 6, 2016
Last Update Posted:
Jul 26, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dong-Xin Wang, Professor and Chairman, Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 26, 2021